Genomic testing (Oncomine Dx Target Test Multi-CDx system®) of precordium skin metastasis (70% tumor cell content) revealed a mutation of BRAF K601E with a variant allele frequency of 17.4% (Figure 1E). The gene discussed is BRAF; the disease is neoplasm.